BeStock  
Stocks › Biotechnology › INVA

Innoviva INVA

US equityMarket cap rank #2978Biotechnology
$18.41 +$0.00 (0.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.41 0.00%
Open$18.41
Prev close$18.41
Day range$18.33 – $18.79
Volume1.15M
Market cap$1.31B
P/E (TTM)7.8
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$106.12M-1.6% YoY
Operating profit$42.15M+21.9% YoY
Net profit-$73.89M-182.2% YoY
Diluted EPS-$1.03-195.4% YoY
Free cash flow$41.67M+6.2% YoY
Operating cash flow$41.70M

Revenue, last 8 quarters

$91.8MDec '24$88.6MMar '25$100.3MJun '25$107.8MSep '25$114.6MDec '25$98.0MMar '26$119.6MJun '26$106.1MSep '26

Net profit, last 8 quarters

$20.3MDec '24$-46.6MMar '25$63.7MJun '25$89.9MSep '25$164.2MDec '25$186.6MMar '26$-83.4MJun '26$-73.9MSep '26

Diluted EPS by quarter

0.26Dec '24-0.74Mar '250.77Jun '251.08Sep '251.94Dec '252.22Mar '26-1.14Jun '26-1.03Sep '26

Free cash flow by quarter

$55.2MDec '24$48.6MMar '25$44.1MJun '25$39.2MSep '25$54.5MDec '25$34.8MMar '26$51.5MJun '26$41.7MSep '26

Annual revenue

$336.8MFY20$391.9MFY21$331.3MFY22$310.5MFY23$358.7MFY24$411.3MFY25

Profitability & balance sheet

Gross margin80.5%
Operating margin38.8%
Net margin44.1%
Return on equity18.0%
Return on assets13.0%
Return on invested capital13.8%
Current ratio15.44
Liabilities / assets26.0%
Cash & investments$590.06M
Total debt$269.11M
Net cash (debt)$320.95M
Free cash flow / sales41.6%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Royalty revenue$54.66M 51.5%
  • GIAPREZA$23.23M 21.9%
  • XACDURO$22.00M 20.7%
  • XERAVA$3.59M 3.4%
  • License and other revenue$2.02M 1.9%
  • ZEVTERA$624,000.00 0.6%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $106.12M $119.59M $97.99M $411.33M $114.61M
Total Operating Revenue $106.12M $119.59M $97.99M $411.33M $114.61M
Cost of Revenue $21.74M $28.98M $15.61M $77.38M $12.67M
Gross Profit $84.38M $90.62M $82.39M $333.94M $101.94M
Operating Expense $42.23M $39.76M $44.23M $170.20M $62.96M
Selling and Admin Expenses $37.02M $34.57M $32.44M $113.32M $32.12M
Research & Development $5.21M $5.19M $5.24M $30.60M $4.56M
Operating Profit $42.15M $50.86M $38.15M $163.75M $38.99M
Net Non-Operating Interest Income (Expense) -$156,000.00 $2.13M $5.55M $4.39M $2.84M
Non-Operating Interest Income $5.32M $7.60M $10.99M $21.09M $6.15M
Non-Operating Interest Expense $5.47M $5.47M $5.44M $16.70M $3.31M
Other Income (Expense) -$139.61M -$161.00M $190.86M $158.73M $153.21M
Gain on Sale of Security -$41.90M -$29.15M $33.58M $20.16M $42.67M
Earnings from Equity Interest -$97.59M -$131.83M $157.65M $141.43M $111.15M
Other Non-Operating Income (Expenses) -$118,000.00 -$15,000.00 -$366,000.00 -$2.86M -$612,000.00
Pretax Profit -$97.61M -$108.02M $234.56M $326.86M $195.04M
Tax -$23.72M -$24.60M $47.97M $55.70M $30.88M
Net Profit -$73.89M -$83.42M $186.60M $271.17M $164.15M
Profit from Continuing Operations -$73.89M -$83.42M $186.60M $271.17M $164.15M
Net Income to Parent Company -$73.89M -$83.42M $186.60M $271.17M $164.15M
Net Income to Common Stockholders -$73.89M -$83.42M $186.60M $271.17M $164.15M
Basic EPS -$1.03 -$1.14 $2.52 $4.02 $2.19
Diluted EPS -$1.03 -$1.14 $2.22 $3.30 $1.94
Dividend Per Share $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization & Depletion – – $6.55M $26.28M –
-Depreciation & Amortization – – $6.55M $26.28M –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.54B $1.70B $1.84B $1.64B $1.64B
Total Current Assets $772.25M $753.37M $772.62M $727.52M $727.52M
Cash and Cash Equivalents & Short-Term Investments $590.06M $579.06M $611.93M $566.67M $566.67M
-Cash and Cash Equivalents $581.39M $570.39M $603.09M $550.94M $550.94M
-Short Term Investments $8.67M $8.67M $8.85M $15.73M $15.73M
Receivables $102.13M $110.62M $92.63M $93.32M $93.32M
-Accounts Receivable $44.02M $50.83M $34.01M $34.97M $34.97M
-Other Receivables $58.11M $59.79M $58.62M $58.35M $58.35M
Prepaid Assets $33.98M $24.41M $24.84M $26.72M $26.72M
Inventory $42.84M $38.97M $38.84M $39.17M $39.17M
Other Current Assets $3.24M $313,000.00 $4.38M $1.64M $1.64M
Total Non-Current Assets $765.67M $949.36M $1.06B $907.65M $907.65M
Net PPE $12.14M $12.51M $12.79M $12.48M $12.48M
-Gross PPE $12.14M $12.51M $12.79M $12.48M $12.48M
Investments and Advances $526.79M $660.85M $764.45M $598.22M $598.22M
-Long Term Equity Investment $526.79M $660.85M $764.45M $598.22M $598.22M
Non Current Accounts Receivables $45.77M $49.23M $52.68M $56.14M $56.14M
Goodwill and Other Intangible Assets $180.18M $186.88M $193.51M $200.06M $200.06M
-Goodwill $17.91M $17.91M $17.91M $17.91M $17.91M
-Other Intangible Assets $162.28M $168.98M $175.60M $182.16M $182.16M
Other Non-Current Assets $792,000.00 $39.89M $40.53M $40.74M $40.74M
Total Liabilities $400.41M $469.47M $494.93M $462.32M $462.32M
Total Current Liabilities $50.03M $47.06M $36.56M $49.70M $49.70M
Payables $10.79M $8.16M $10.44M $8.93M $8.93M
-Accounts Payable $6.50M $4.02M $6.52M $4.97M $4.97M
-Total Tax Payable $0.00 $0.00 $0.00 $274,000.00 $274,000.00
-Other Payable $4.29M $4.15M $3.92M $3.69M $3.69M
Current Accrued Expenses $25.76M $25.87M $17.10M $27.95M $27.95M
Short-Term Debt and Capital Lease Obligation $759,000.00 $712,000.00 $646,000.00 $418,000.00 $418,000.00
-Current Capital Lease Obligation $759,000.00 $712,000.00 $646,000.00 $418,000.00 $418,000.00
Current Deferred Liabilities $12.73M $12.32M $8.37M $12.39M $12.39M
Total Non-Current Liabilities $350.38M $422.40M $458.37M $412.63M $412.63M
Long Term Accounts Payable and Other Payables $19.41M $59.93M $58.35M $57.01M $57.01M
Long Term Debt and Capital Lease Obligation $269.11M $268.95M $268.78M $268.60M $268.60M
-Long Term Debt $258.82M $258.45M $258.10M $257.73M $257.73M
-Long Term Capital Lease Obligation $10.29M $10.49M $10.68M $10.87M $10.87M
Non-Current Deferred Liabilities $60.36M $92.02M $130.13M $85.90M $85.90M
Other Non-Current Liabilities $1.51M $1.51M $1.12M $1.12M $1.12M
Total Equity $1.14B $1.23B $1.34B $1.17B $1.17B
Stockholders' Equity $1.14B $1.23B $1.34B $1.17B $1.17B
Capital Stock $716,000.00 $727,000.00 $738,000.00 $747,000.00 $747,000.00
-Common Stock $716,000.00 $727,000.00 $738,000.00 $747,000.00 $747,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $838.15M $859.99M $884.95M $902.73M $902.73M
Retained Earnings $298.66M $372.54M $455.96M $269.37M $269.37M
Non-Current Deferred Assets – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $41.70M $51.97M $35.28M $196.93M $54.51M
Net cash flow from continuing operations $41.70M $51.97M $35.28M $196.93M $54.51M
Net Income from Continuing Operations -$73.89M -$83.42M $186.60M $271.17M $164.15M
Depreciation & Depletion & Amortization $6.70M $6.63M $6.55M $26.28M $6.64M
Deferred Tax -$29.83M -$36.09M $41.04M $43.85M $39.78M
Other Non-Cash Items $4.77M $4.93M $6.03M $22.58M $6.07M
Change in Working Capital -$9.21M -$5.80M -$16.27M -$24.16M -$10.81M
-Change in Receivables $8.49M -$17.99M $690,000.00 -$6.95M $202,000.00
-Change in Inventory -$4.60M -$1.03M -$1.31M -$12.92M -$2.62M
-Change in Prepaid Assets -$9.57M $429,000.00 $1.88M -$5.66M -$7.31M
-Change in Payables and Accrued Expense -$38.70M $8.12M -$8.57M -$700,000.00 $10.30M
-Change in Other Current Assets $36.17M $2.33M -$8.37M -$1.08M -$2.08M
-Change In Other Working Capital -$1.01M $2.34M -$593,000.00 $3.14M -$9.30M
Net cash flow from investing -$5.43M -$55.26M $37.01M $40.50M $23.64M
Net Cash Flow from Continuing Investing Activities -$5.43M -$55.26M $37.01M $40.50M $23.64M
Net PPE Purchase and Sale $1,000.00 -$244,000.00 -$492,000.00 -$1.12M $2,000.00
Net Business Purchase and Sale $0.00 $3.28M $40.84M $28.16M $8.23M
Net Investment Purchase and Sale -$5.43M -$58.30M -$3.34M $22.82M $15.41M
Financing Cash Flow -$25.26M -$29.41M -$20.15M $8.55M -$3.72M
Net Cash Flow from Continuing Financing Activities -$25.26M -$29.41M -$20.15M $8.55M -$3.72M
Net Common Stock Issuance -$25.26M -$29.41M -$20.15M -$2.12M -$3.72M
Ending Cash Balance $581.39M $570.39M $603.09M $550.94M $550.94M
Net Change in Cash $11.01M -$32.70M $52.14M $245.98M $74.43M
Beginning Cash Balance $570.39M $603.09M $550.94M $304.96M $476.51M
Free Cash Flow $41.67M $51.54M $34.79M $186.43M $54.50M
Gain/Loss from Continuing Operations – – – $9.37M $0.00
Net Intangibles Purchase and Sale – – – -$9.37M $0.00
Net Issuance Payments Of Debt – – – $0.00 $25,000.00
Proceeds from Stock Option Exercised – – – $10.70M $0.00
Net Other Financing Charges – – – -$25,000.00 –

Discussion

No comments yet — be the first to weigh in on INVA.

Sign in to join the discussion.

Scroll to Top